510(k) Report

510(k) · Cleared

Cleared

AuraGen 123 Suction Lipoplasty System (A123)

K190278510(k) TraditionalCleared May 3, 201984-day reviewClass II21 CFR 878.5040

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Auragen Aesthetics, LLC · MUU System, Suction, Lipoplasty

Cleared on May 3, 2019 as substantially equivalent to K120902 (The Gid Group, Inc., 2012) after an 84-day review. Its family tree reaches back 8 generations to 1991.

Decided
May 3, 2019
Review
84 days
Class
Class II
Product code
MUU
Recalls
None
Predicates
1

Its longest line of descent runs back 8 generations to K910696 (1991). 28 ancestors in all, the oldest K861153 (1986). No later device cites it as a predicate yet.

  1. Root · 8 generations backK910696 Cusa (R) System 200C/200T/200M/200H Ultra AspiratorValleylab, Inc. · 1991
  2. 7 generations backK970471 Mentor Ultrasound Assisted Tissue Removal System (TRS)Mentor Corp. · 1997
  3. 6 generations backK983065 Mentor Ultrasound-Assisted Tissue Removal SystemMentor Corp. · 1998
  4. 5 generations backK022051 Soundvaser SystemSound Surgical Technologies, LLC · 2002 · Recalled
  5. 4 generations backK042261 Macropore Puricel Lipoplasty SystemMacropore Biosurgery, Inc. · 2004
  6. 3 generations backK072587 Cytori Aft SystemCytori Therapeutics, Inc. · 2007
  7. 2 generations backK092482 Tissu Trans Filtron, Models 3-TT-Filtron 2000-500Shippert Medical Technologies Corp. · 2009 · Recalled
  8. 1 generation backK120902 GID 700The Gid Group, Inc. · 2012 · Recalled
  9. This deviceK190278 AuraGen 123 Suction Lipoplasty System (A123)Auragen Aesthetics, LLC · 2019
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K910696Cusa (R) System 200C/200T/200M/200H Ultra AspiratorValleylab, Inc.1991—
−7K970471Mentor Ultrasound Assisted Tissue Removal System (TRS)Mentor Corp.1997—
−6K983065Mentor Ultrasound-Assisted Tissue Removal SystemMentor Corp.1998—
−5K022051Soundvaser SystemSound Surgical Technologies, LLC20022
−4K042261Macropore Puricel Lipoplasty SystemMacropore Biosurgery, Inc.2004—
−3K072587Cytori Aft SystemCytori Therapeutics, Inc.2007—
−2K092482Tissu Trans Filtron, Models 3-TT-Filtron 2000-500Shippert Medical Technologies Corp.20098
−1K120902GID 700The Gid Group, Inc.20121
0 (this device)K190278AuraGen 123 Suction Lipoplasty System (A123)Auragen Aesthetics, LLC2019—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198620
198820
199210
199410
199520
199620
199720
199830
199930
200110
200510
FIG. 1 — Lineage of K190278, 1991–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MUU? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MUU device

  1. #1 K210528 IntelliFat Disposable Adipose Tissue…score 5.7 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K120902GID 700
Summary page 4
…: A123 Classification Name: Suction Lipoplasty System Regulatory Class: Class II Product Code: MUU (General and Plastic Surgery Panel) Predicate Device 510(K) # K120902 Trade name: GID 700 Tissue Canister Manufacturer: The GID Group, USA (Distributed in the US as REVOLVE™ Syst…
The Gid Group, Inc.20121

Also cleared against K120902: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 28 years and passes through 8 companies; a new generation was cleared every 3.2 years on median.
  • 6 of the 28 ancestors have a recall of any class.
  • 4 other devices also cite its predicate K120902.

How does its category compare?

All MUU devices

MUU System, Suction, Lipoplasty: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · MUU

1in 2022

2007: 12008: 12009: 32010: 42012: 52013: 12014: 42015: 32016: 12017: 72018: 12019: 42020: 22021: 22022: 1
2007high 7 (2017) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MUU

190in 2019

2009: 113 days median2010: 58 days median2012: 171 days median2014: 114 days median2015: 269 days median2017: 91 days median2019: 190 days median
2007high 269 (2015) · low 58 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MUU

2in 2017

2007: 12015: 12016: 12017: 2
2007high 2 (2017) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MUU

10in 2025

2007: 22008: 42009: 22010: 42011: 52012: 42013: 212014: 132015: 442016: 202017: 282018: 302019: 352020: 362021: 282022: 502023: 152024: 52025: 10
2007high 50 (2022) · low 2 (2007)2025

MAUDE reports naming product code MUU, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—12
20081—04
2009311302
201045804
20110—05
2012517104
20131—021
20144114013
20153269144
20161—120
2017791228
20181—030
20194190035
20202—036
20212—028
20221—050
20230—015
20240—05
20250—010
20260—0—

What is it indicated for?

The A123 is used for aspiration, harvesting, filtering and transferring of autologous adipose tissue for aesthetic body contouring. The system should be used with a legally marketed vacuum or aspirator apparatus as a source of suction. If harvested fat is to be re-implanted, the harvested fat is to be used without any additional manipulation.

The A123 is intended for use in the following surgical specialties when aspiration of soft tissue is desired: plastic and reconstructive surgery, neurosurgery, gastrointestinal and affiliated organ surgery, urological surgery, general surgery, orthopedic surgery, gynecological surgery, thoracic surgery, and laparoscopic surgery.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K190278: AuraGen 123 Suction Lipoplasty System (A123).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K190278

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026